Cargando…

Management of hemodynamically stable wide QRS complex tachycardia in patients with implantable cardioverter defibrillators

Management of hemodynamically stable, incessant wide QRS complex tachycardia (WCT) in patients who already have an implantable cardioverter defibrillator (ICD) is challenging. First-line treatment is performed by medical staff who have no knowledge on programmed ICD therapy settings and there is alw...

Descripción completa

Detalles Bibliográficos
Autores principales: Regoli, François D., Cattaneo, Mattia, Kola, Florenc, Thartori, Albana, Bytyci, Hekuran, Saccarello, Luca, Amoruso, Marco, Di Valentino, Marcello, Menafoglio, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846131/
https://www.ncbi.nlm.nih.gov/pubmed/36684577
http://dx.doi.org/10.3389/fcvm.2022.1011619
_version_ 1784871090866094080
author Regoli, François D.
Cattaneo, Mattia
Kola, Florenc
Thartori, Albana
Bytyci, Hekuran
Saccarello, Luca
Amoruso, Marco
Di Valentino, Marcello
Menafoglio, Andrea
author_facet Regoli, François D.
Cattaneo, Mattia
Kola, Florenc
Thartori, Albana
Bytyci, Hekuran
Saccarello, Luca
Amoruso, Marco
Di Valentino, Marcello
Menafoglio, Andrea
author_sort Regoli, François D.
collection PubMed
description Management of hemodynamically stable, incessant wide QRS complex tachycardia (WCT) in patients who already have an implantable cardioverter defibrillator (ICD) is challenging. First-line treatment is performed by medical staff who have no knowledge on programmed ICD therapy settings and there is always some concern for unexpected ICD shock. In these patients, a structured approach is necessary from presentation to therapy. The present review provides a systematic approach in four distinct phases to guide any physician involved in the management of these patients: PHASE I: assessment of hemodynamic status and use of the magnet to temporarily suspend ICD therapies, especially shocks; identification of possible arrhythmia triggers; risk stratification in case of electrical storm (ES). PHASE II: The preparation phase includes reversal of potential arrhythmia “triggers”, mild patient sedation, and patient monitoring for therapy delivery. Based on resource availability and competences, the most adequate therapeutic approach is chosen. This choice depends on whether a device specialist is readily available or not. In the case of ES in a “high-risk” patient an accelerated patient management protocol is advocated, which considers urgent ventricular tachycardia transcatheter ablation with or without mechanical cardiocirculatory support. PHASE III: Therapeutic phase is based on the use of intravenous anti-arrhythmic drugs mostly indicated in this clinical context are presented. Device interrogation is very important in this phase when sustained monomorphic VT diagnosis is confirmed, then ICD ATP algorithms, based on underlying VT cycle length, are proposed. In high-risk patients with intractable ES, intensive patient management considers MCS and transcatheter ablation. PHASE IV: The patient is hospitalized for further diagnostics and management aimed at preventing arrhythmia recurrences.
format Online
Article
Text
id pubmed-9846131
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98461312023-01-19 Management of hemodynamically stable wide QRS complex tachycardia in patients with implantable cardioverter defibrillators Regoli, François D. Cattaneo, Mattia Kola, Florenc Thartori, Albana Bytyci, Hekuran Saccarello, Luca Amoruso, Marco Di Valentino, Marcello Menafoglio, Andrea Front Cardiovasc Med Cardiovascular Medicine Management of hemodynamically stable, incessant wide QRS complex tachycardia (WCT) in patients who already have an implantable cardioverter defibrillator (ICD) is challenging. First-line treatment is performed by medical staff who have no knowledge on programmed ICD therapy settings and there is always some concern for unexpected ICD shock. In these patients, a structured approach is necessary from presentation to therapy. The present review provides a systematic approach in four distinct phases to guide any physician involved in the management of these patients: PHASE I: assessment of hemodynamic status and use of the magnet to temporarily suspend ICD therapies, especially shocks; identification of possible arrhythmia triggers; risk stratification in case of electrical storm (ES). PHASE II: The preparation phase includes reversal of potential arrhythmia “triggers”, mild patient sedation, and patient monitoring for therapy delivery. Based on resource availability and competences, the most adequate therapeutic approach is chosen. This choice depends on whether a device specialist is readily available or not. In the case of ES in a “high-risk” patient an accelerated patient management protocol is advocated, which considers urgent ventricular tachycardia transcatheter ablation with or without mechanical cardiocirculatory support. PHASE III: Therapeutic phase is based on the use of intravenous anti-arrhythmic drugs mostly indicated in this clinical context are presented. Device interrogation is very important in this phase when sustained monomorphic VT diagnosis is confirmed, then ICD ATP algorithms, based on underlying VT cycle length, are proposed. In high-risk patients with intractable ES, intensive patient management considers MCS and transcatheter ablation. PHASE IV: The patient is hospitalized for further diagnostics and management aimed at preventing arrhythmia recurrences. Frontiers Media S.A. 2023-01-04 /pmc/articles/PMC9846131/ /pubmed/36684577 http://dx.doi.org/10.3389/fcvm.2022.1011619 Text en Copyright © 2023 Regoli, Cattaneo, Kola, Thartori, Bytyci, Saccarello, Amoruso, Di Valentino and Menafoglio. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Regoli, François D.
Cattaneo, Mattia
Kola, Florenc
Thartori, Albana
Bytyci, Hekuran
Saccarello, Luca
Amoruso, Marco
Di Valentino, Marcello
Menafoglio, Andrea
Management of hemodynamically stable wide QRS complex tachycardia in patients with implantable cardioverter defibrillators
title Management of hemodynamically stable wide QRS complex tachycardia in patients with implantable cardioverter defibrillators
title_full Management of hemodynamically stable wide QRS complex tachycardia in patients with implantable cardioverter defibrillators
title_fullStr Management of hemodynamically stable wide QRS complex tachycardia in patients with implantable cardioverter defibrillators
title_full_unstemmed Management of hemodynamically stable wide QRS complex tachycardia in patients with implantable cardioverter defibrillators
title_short Management of hemodynamically stable wide QRS complex tachycardia in patients with implantable cardioverter defibrillators
title_sort management of hemodynamically stable wide qrs complex tachycardia in patients with implantable cardioverter defibrillators
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846131/
https://www.ncbi.nlm.nih.gov/pubmed/36684577
http://dx.doi.org/10.3389/fcvm.2022.1011619
work_keys_str_mv AT regolifrancoisd managementofhemodynamicallystablewideqrscomplextachycardiainpatientswithimplantablecardioverterdefibrillators
AT cattaneomattia managementofhemodynamicallystablewideqrscomplextachycardiainpatientswithimplantablecardioverterdefibrillators
AT kolaflorenc managementofhemodynamicallystablewideqrscomplextachycardiainpatientswithimplantablecardioverterdefibrillators
AT thartorialbana managementofhemodynamicallystablewideqrscomplextachycardiainpatientswithimplantablecardioverterdefibrillators
AT bytycihekuran managementofhemodynamicallystablewideqrscomplextachycardiainpatientswithimplantablecardioverterdefibrillators
AT saccarelloluca managementofhemodynamicallystablewideqrscomplextachycardiainpatientswithimplantablecardioverterdefibrillators
AT amorusomarco managementofhemodynamicallystablewideqrscomplextachycardiainpatientswithimplantablecardioverterdefibrillators
AT divalentinomarcello managementofhemodynamicallystablewideqrscomplextachycardiainpatientswithimplantablecardioverterdefibrillators
AT menafoglioandrea managementofhemodynamicallystablewideqrscomplextachycardiainpatientswithimplantablecardioverterdefibrillators